Deep Track Capital, LP 13D/13G Filings for Regulus Therapeutics Inc. (RGLS)

Deep Track Capital, LP 13D and 13G filings for Regulus Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-03-22
4:03 pm
Purchase
2024-03-12 13G Regulus Therapeutics Inc.
RGLS
Deep Track Capital, LP 6,888,424
9.990%
6,888,424increase
(New Position)
Filing